Form 4: Quaker Chemical Director Mark Douglas Reports Stock Transactions and New RSU Grant

Sentiment:

Insider Transaction Report


Quaker Chemical Corp. Director Mark Douglas reported the conversion of restricted stock units and dividend equivalent rights into common stock, alongside a new grant of restricted stock units as part of his 2025 compensation.

Summary

  • Mark Douglas, a Director at Quaker Chemical Corp. (KWR), reported changes in his beneficial ownership of company securities.
  • On May 31, 2025, 716 Restricted Stock Units (RSUs) converted into common stock on a one-for-one basis.
  • Also on May 31, 2025, 9 Dividend Equivalent Rights (DERs) settled into common stock, which accrued as dividends were paid on KWR common stock.
  • These 716 RSUs were granted on June 1, 2024, and vested 100% on May 31, 2025.
  • Following these transactions, Mr. Douglas beneficially owned 4,296 shares of KWR Common Stock directly.
  • On June 1, 2025, Mr. Douglas was granted an additional 1,198 time-based Restricted Stock Units under the Company's Long-Term Performance Incentive Plan.
  • These new RSUs are part of his 2025 compensation as a non-executive director and vest 100% on May 31, 2026.
  • Dividend equivalent rights will accrue on these new RSUs when and as dividends are paid on KWR's common stock.

Sentiment

Score: 7

Explanation: The document reports routine equity compensation and vesting events for a director, which are generally positive for aligning management interests with shareholders but do not indicate significant new positive or negative developments for the company's operations or financials.

Positives

  • The grant of 1,198 new Restricted Stock Units aligns the director's interests with long-term shareholder value.
  • The vesting of previous RSUs and DERs indicates a successful completion of prior compensation cycles.

Future Outlook

The grant of new Restricted Stock Units to Director Mark Douglas, vesting on May 31, 2026, indicates a continued long-term incentive structure for non-executive directors, aligning their compensation with future company performance.

Industry Context

This Form 4 filing reflects standard equity compensation practices for non-executive directors in publicly traded companies, aiming to align their interests with long-term shareholder value through stock-based incentives.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation StructureThe grant of time-based restricted stock units to non-executive directors as part of their 2025 compensation under the Company's Long-Term Performance Incentive Plan reinforces the existing equity-based compensation framework.06/01/2025Aligns director incentives with long-term shareholder value and company performance.

Stakeholder Impact

  • Shareholders: The equity grants align the director's interests with shareholders, potentially fostering long-term value creation.

Next Steps

  • The 1,198 Restricted Stock Units granted on June 1, 2025, are expected to vest on May 31, 2026.
  • Dividend equivalent rights will continue to accrue on the newly granted Restricted Stock Units as dividends are paid on KWR's common stock.

Key Dates

DateDescription
06/01/2024Date when 716 Restricted Stock Units (RSUs) were granted to Mark Douglas.
05/31/2025Date of conversion of 716 Restricted Stock Units and settlement of 9 Dividend Equivalent Rights into Common Stock.
06/01/2025Date of grant of 1,198 new time-based Restricted Stock Units to Mark Douglas.
06/03/2025Signature date of the filing by Victoria K. Gehris, Attorney-in-Fact for Mark A. Douglas.
05/31/2026Vesting date for the 1,198 Restricted Stock Units granted on June 1, 2025.

Recommendation

hold

Keywords

Quaker Chemical Corp, KWR, SEC Form 4, Insider Transaction, Restricted Stock Units, Dividend Equivalent Rights, Director Compensation, Equity Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.